Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03939858 · ClinicalTrials.gov registry record
Bioenergetic Profiling and Cognition in GBM Patients
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 6
- Enrollment target
NCT03939858 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants.
The verdict
NCT03939858 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This trial studies the use of blood-based bioenergetic profiling and cognitive testing in assessing patients with glioblastoma undergoing chemoradiation therapy. The purpose of this pilot research study is to find out if it is possible to see changes in participants' mitochondria, parts of a cell that produce energy, that might be associated with changes in participants' brain function after chemoradiation therapy.
Interventions
- PROCEDURE Cognitive Assessment
- DIAGNOSTIC_TEST Blood Collection
- DIAGNOSTIC_TEST Bioenergetic Profiling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-10-24 |
| Est. Completion | 2023-06-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03939858
The ClinicalTrials.gov registry entry for NCT03939858 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cognitive Assessment is the first listed.
NCT03939858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03939858 about?
NCT03939858 is a clinical study titled "Bioenergetic Profiling and Cognition in GBM Patients". This trial studies the use of blood-based bioenergetic profiling and cognitive testing in assessing patients with glioblastoma undergoing chemoradiation therapy. The purpose of this pilot research study is to find out if it is possible to see changes in participants' mitochondria, parts of a cell th...
What is the current status of trial NCT03939858?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2019-10-24. Estimated completion is 2023-06-09.
What interventions are being tested in trial NCT03939858?
The interventions under investigation include: Cognitive Assessment (PROCEDURE), Blood Collection (DIAGNOSTIC_TEST), Bioenergetic Profiling (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03939858?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.